Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children
Clinical trial NCT01328886 · COMPLETED
Trial details
- NCT number
- NCT01328886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.